The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics.

Vancomycin, LY264826 and four N-substituted derivatives of LY264826 were examined for dimerization, binding to D-alanyl-D-alanine- and D-alanyl-D-lactate-containing cell wall ligands, and binding to bacterial membrane vesicles. The six glycopeptide antibiotics represent a 360-fold range in antibacterial activities against Micrococcus luteus (MIC = 0.00072-0.26 microM) with the N-substituted compounds having the lowest MICs. Vancomycin, LY264826 and the four N-substituted derivatives shared nearly identical binding affinities for N,N'-diacetyl-L-lysyl-D-alanyl-D-alanine (Kb = 1.5 x 10(5) approximately 5.9 x 10(5) M-1). Affinities for binding N,N'-diacetyl-L-lysyl-D-alanyl-D-lactate were lower but also represented a narrow range (Kb = 0.24 x 10(3) approximately 1.6 x 10(3) M-1). In contrast to ligand binding, the relative capacity of the six compounds to dimerize differed by four orders of magnitude (Kdim = 4.9 x 10(1)-1.2 x 10(6) M-1). The N-substituted derivatives had the highest Kdim values, required the greatest molar excess of exogenous cell wall ligand to suppress inhibition, and demonstrated a propensity to bind to bacterial membrane vesicles. The derivatives with the most lipophilic side chains were the most highly bound to vesicles. The findings suggest that the enhanced antibacterial activities of N-substituted derivatives of LY264826 derive from the nature of the hydrophobic side chain which can have a marked effect on dimerization and membrane binding.

[1]  F. Parenti,et al.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties. , 1978, The Journal of antibiotics.

[2]  Dudley H. Williams,et al.  Glycopeptide antibiotic activity and the possible role of dimerization : A model for biological signaling , 1994 .

[3]  K. Rolston,et al.  In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer , 1990, Antimicrobial Agents and Chemotherapy.

[4]  C. Walsh,et al.  Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. , 1991, Biochemistry.

[5]  G. Whitesides,et al.  Affinity capillary electrophoresis can simultaneously measure binding constants of multiple peptides to vancomycin , 1992 .

[6]  S. Handwerger,et al.  Binding studies of vancomycin to the cytoplasmic peptidoglycan precursors by affinity capillary electrophoresis. , 1994, Analytical chemistry.

[7]  S. Handwerger,et al.  The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate , 1992, Journal of bacteriology.

[8]  T. F. Butler,et al.  Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity. , 1996, The Journal of antibiotics.

[9]  Dudley H. Williams,et al.  Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics , 1995, Antimicrobial agents and chemotherapy.

[10]  P. Reynolds,et al.  Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. , 1992, FEMS microbiology letters.

[11]  N. Allen,et al.  Use of capillary electrophoresis to measure dimerization of glycopeptide antibiotics. , 1997, Analytical biochemistry.

[12]  H. Perkins,et al.  Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine. , 1971, The Biochemical journal.

[13]  J. Richardson,et al.  Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. , 1992, FEMS microbiology letters.

[14]  G. Whitesides,et al.  Determination of binding constants of ligands to proteins by affinity capillary electrophoresis: compensation for electroosmotic flow. , 1994, Analytical chemistry.

[15]  W. Konings,et al.  New Procedure for the Isolation of Membrane Vesicles of Bacillus subtilis and an Electron Microscopy Study of Their Ultrastructure , 1973, Journal of bacteriology.

[16]  D. Williams,et al.  The structure and mode of action of glycopeptide antibiotics of the vancomycin group. , 1984, Annual review of microbiology.

[17]  N. Allen,et al.  Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues , 1997, Antimicrobial agents and chemotherapy.

[18]  Dudley H. Williams,et al.  Cooperativity in ligand binding expressed at a model cell membrane by the vancomycin group antibiotics , 1996 .

[19]  R. Jones,et al.  In vitro activity and spectrum of LY333328, a novel glycopeptide derivative , 1997, Antimicrobial agents and chemotherapy.

[20]  T. Nicas,et al.  Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis , 1989, Antimicrobial Agents and Chemotherapy.

[21]  V. Good,et al.  MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine. , 1990, The Journal of antibiotics.

[22]  Dudley H. Williams,et al.  Aspects of molecular recognition: solvent exclusion and dimerization of the antibiotic ristocetin when bound to a model bacterial cell-wall precursor , 1989 .

[23]  T. Nicas,et al.  Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic , 1996, Antimicrobial agents and chemotherapy.

[24]  H. Perkins,et al.  THE CHEMICAL BASIS FOR THE ACTION OF THE VANCOMYCIN GROUP OF ANTIBIOTICS , 1974, Annals of the New York Academy of Sciences.

[25]  D. M. Berry,et al.  Conversion of antibiotic A82846B to orienticin A and structural relationships of related antibiotics , 1989 .

[26]  U. Gerhard,et al.  Two conformers of the glycopeptide antibiotic teicoplanin with distinct ligand binding sites. , 1995, The Journal of antibiotics.

[27]  Dudley H. Williams,et al.  The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics , 1993 .

[28]  R. Nagarajan.  Structure-activity relationships of vancomycin-type glycopeptide antibiotics. , 1993, The Journal of antibiotics.

[29]  Joel P. Mackay,et al.  Dissection of the contributions toward dimerization of glycopeptide antibiotics , 1994 .

[30]  J. Mackay,et al.  The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics. , 1994, Structure.

[31]  W. Jencks,et al.  On the attribution and additivity of binding energies. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Nicas,et al.  Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria , 1995, Antimicrobial agents and chemotherapy.

[33]  R. Thompson,et al.  Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci , 1996, Antimicrobial agents and chemotherapy.

[34]  G. Rivas,et al.  Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. , 1996, The Journal of antibiotics.